Paul Wordsworth

Paul Wordsworth qualified in medicine from the Westminster Medical School, University of London, in 1975 and trained in general internal medicine in London prior to specialist training in rheumatology at the Middlesex Hospital in 1981. He completed training in the Oxford Region where he was appointed to a Senior Research Fellowship and Honorary Consultant position in 1987. Subsequently, he was appointed Clinical Reader in Rheumatology in 1992 and elected to a Personal Chair in 1998. He has been a Fellow of Green Templeton College since 1992.

His main research interests particularly are in the genetic basis of disorders of the musculoskeletal system, ranging from rare monogenic developmental disorders through to common polygenic diseases such as ankylosing spondylitis and rheumatoid arthritis. He has authored or co-authored more than 250 original papers including work on genetic and clinical aspects of osteogenesis imperfecta, chrondrodysplasias, Marfan syndrome and ectopic ossification and calcification.

He has run the clinical trials unit at the Nuffield Orthopaedic Centre in Oxford for the past 10 years, including several studies of biologic agents in AS. He is a founder member of 2 major research consortia for AS, the International Genetics of AS (IGAS) and the Australo-Anglo-American (Triple A) Spondylitis Consortium (TASC) that have recently published their findings in Nature Genetics.